ARTICLE | Financial News

Liver company Vital revives IPO plans

March 12, 2014 12:42 AM UTC

Vital Therapies Inc. (San Diego, Calif.) revitalized plans for an IPO on NASDAQ. The company postponed its IPO in November, citing market conditions. On Tuesday, Vital filed an S-1A that no longer contains a share price or proposed number of shares. BofA Merrill Lynch; Credit Suisse; William Blair; and Canaccord are listed as underwriters.

Before postponing its IPO, Vital had planned to sell 4.4 million shares at $16-$18. At the $17 midpoint, the company would have raised $74.8 million and been valued at $277.4 million. ...